Cart
sales@molnova.com
uk-50001
CAS No. 857900-47-1
uk-50001( —— )
Catalog No. M36004 CAS No. 857900-47-1
uk-50001 is a phosphodiesterase (PDE) 4 inhibitor that can be used for many diseases, especially inflammation, allergies, respiratory diseases, disorders and conditions and wounds.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 470 | In Stock |
|
| 5MG | 380 | In Stock |
|
| 10MG | 570 | In Stock |
|
| 25MG | 911 | In Stock |
|
| 50MG | 1190 | In Stock |
|
| 100MG | 1628 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 3246 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nameuk-50001
-
NoteResearch use only, not for human use.
-
Brief Descriptionuk-50001 is a phosphodiesterase (PDE) 4 inhibitor that can be used for many diseases, especially inflammation, allergies, respiratory diseases, disorders and conditions and wounds.
-
Descriptionuk-50001 is a phosphodiesterase (PDE) 4 inhibitor that can be used for many diseases, especially inflammation, allergies, respiratory diseases, disorders and conditions and wounds.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number857900-47-1
-
Formula Weight499.48
-
Molecular FormulaC26H24F3N3O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C1=C(C(NC2CCC(NC(=O)C3=C(O)C=CC(C)=C3)CC2)=O)C=C(F)C=N1)C4=CC(F)=C(F)C=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
CI-1044
CI-1044 is a potent, selective and orally bioavailable PDE4 inhibitor with IC50 of 0.27 uM.
-
Nanterinone
Nanterinone (UK 61260), an orally available partial phosphodiesterase inhibitor, is a novel positive inotropic and balanced vasodilator compound.
-
ATX inhibitor 5
ATX inhibitor 5 is a potent and orally active autotaxin (ATX) inhibitor (IC50: 15.3 nM) that reduces CCl4-induced hepatic fibrosis and exhibits anti-hepatic fibrosis effects.
